Update 1990 pp 836-850 | Cite as

Intensive Care for Complications of Malignant Disease: Presentation and Outcome

  • C. J. Hinds
  • E. H. S. Yau
Conference paper
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 10)

Abstract

In recent years there have been many important advances in the management of malignant disease and as a result cancer is no longer inevitably fatal. Although there have been some significant developments in the management of solid tumors, the most dramatic improvements in long term outcome have been seen in patients with hematological and lymphoreticular malignancies, a significant proportion of whom can now be cured with aggressive chemotherapy [1, 2]. There have also been important improvements in supportive care; in particular the administration of platelet concentrates has reduced the incidence of fatal thrombocytopenic hemorrhage and the development of specialist nursing techniques, combined with the more effective use of anti-microbial agents has greatly reduced the mortality from intercurrent infection.

Keywords

Lymphoma Dopamine Corticosteroid Pneumonia Oncol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Scott RB (1957) Leukaemia. Lancet 1:1053–1058CrossRefGoogle Scholar
  2. 2.
    Bassan R, Rohatiner AZS, Gregory W, Amess J, Binils R, Barnett MJ, Lister TA (1987) The treatment of acute myelogenous leukaemia. Haematol Blood Transf 31:35–36Google Scholar
  3. 3.
    Sculier JP, Bron D, Verboven M, Klastersky J (1988) Multiple organ failure during interleukin-2 administration and LAK cells infusion. Intensive Care Med 14:666–667PubMedCrossRefGoogle Scholar
  4. 4.
    Dragsted L, Qvist J, Madsen M (1989) Outcome from intensive care II. A 5-year study of 1308 patients: short term outcome. Eur J Anaesthesiol 6:131–144PubMedGoogle Scholar
  5. 5.
    Schuster DP, Marion JM (1983) Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematological malignancy. Am J Med 75:402–408PubMedCrossRefGoogle Scholar
  6. 6.
    Chang HY, Rodriguez V, Narboni G, et al (1976) Causes of death in adults with acute leukaemia. Medicine 55:259–268PubMedCrossRefGoogle Scholar
  7. 7.
    Bodey GP, Bolivar R, Fainstein AV (1982) Infectious complications in leukemic patients. Sem Hematol 19:193–226Google Scholar
  8. 8.
    Lloyd-Thomas AR, Wright I, Lister TA, Hinds CJ (1988) Prognosis of patients receiving intensive care for life threatening medical complications of haematological malignancy. Br Med J 296:1025–1029CrossRefGoogle Scholar
  9. 9.
    Anger B, Schmeiser T, Sigel H, Heimpel H (1987) Intensive care therapy for patients with hematological diseases. Haematol Bluttransfus 30:519–523Google Scholar
  10. 10.
    Bodey GP, Buckley M, Sathe YS, et al (1966) Quantitative relationships between cumulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 64:328–340PubMedGoogle Scholar
  11. 11.
    Turnbull AD, Carlon G, Baron R, Sichel W, Young C, Howland W (1979) The inverse relationship between cost and survival in the critically ill cancer patient. Crit Care Med 7:20–23PubMedCrossRefGoogle Scholar
  12. 12.
    Lloyd-Thomas AR, Dhaliwal HS, Lister TA, Hinds CJ (1986) Intensive therapy for life-threatening medical complications of haematological malignancy. Intensive Care Med 12:317–324PubMedCrossRefGoogle Scholar
  13. 13.
    Ambrus JL, Ambrus CM, Mink IB, Pickern JW (1975) Causes of death in cancer patients. J Med 6:61–64PubMedGoogle Scholar
  14. 14.
    Hauser MJ, Tabak J, Baier H (1982) Survival of patients with cancer in a medical critical care unit. Arch Intern Med 142:527–529PubMedCrossRefGoogle Scholar
  15. 15.
    Johnson MH, Gordon PW, Fitzgerald FT (1986) Stratifaction of prognosis in granulocytopenic patients with haematologic malignancies using the APACHE-II severity of illness score. Crit Care Med 14:693–697PubMedCrossRefGoogle Scholar
  16. 16.
    Snow RM, Miller WC, Rice DL, Ali MK (1979) Respiratory failure in cancer patients. JAMA 241:2039–2042PubMedCrossRefGoogle Scholar
  17. 17.
    Cox SC, Norwood SM, Duncan CA (1985) Acute respiratory failure: Mortality associated with underlying disease. Crit Care Med 13:1005–1008PubMedCrossRefGoogle Scholar
  18. 18.
    Goldiner PL, Pinilla J, Turnbull A (1976) Acute respiratory failure in patients with advanced lymphoma. In: Lacker MJ (ed) Hodgkins disease. Wiley & Sons, New York, pp 371–376Google Scholar
  19. 19.
    Torrecilla C, Cortes JL, Chamorro C, Rubio JJ, Galdos P, De Villota ED (1988) Prognostic assessment of the acute complications of bone marrow transplantation requiring intensive therapy. Intensive Care Med 14:393–398PubMedCrossRefGoogle Scholar
  20. 20.
    Fanta CH, Pennington JE (1981) Fever and new lung infiltrates in the immunocompromised host. Clin Chest Med 2:19–39PubMedGoogle Scholar
  21. 21.
    Estopa R, Marti AT, Kastanos N, et al (1984) Acute respiratory failure in severe hematological disorders. Crit Care Med 12:26–29PubMedCrossRefGoogle Scholar
  22. 22.
    Krowka MJ, Rosenow EC, Hoagland HC (1985) Pulmonary complications of bone marrow transplantation. Chest 87:237–246PubMedCrossRefGoogle Scholar
  23. 23.
    Greenman RL, Goodall PT, King D (1975) Lung biopsy in immunocompromised hosts. Am J Med 59:488–496PubMedCrossRefGoogle Scholar
  24. 24.
    Leight GS, Michaelis LL (1978) Open lung biopsy for the diagnosis of acute, diffuse pulmonary infiltrates in the immunosuppressed patient. Chest 73:477–482PubMedCrossRefGoogle Scholar
  25. 25.
    Hewlett RI, Archie F, Wilson (1977) Adult respiratory distress syndrome (ARDS) following aggressive management of extensive acute lymphoblastic leukaemia. Cancer 39:2422–2425PubMedCrossRefGoogle Scholar
  26. 26.
    Vernant JP, Brun B, Mannoni P, Dreyfus B (1979) Respiratory distress of hyperleukocytic granulocytic leukemias. Cancer 44:264–268PubMedCrossRefGoogle Scholar
  27. 27.
    Haupt MH, Hutchins GM, Moore GW (1981) Ara-C lung: Noncardiogenic pulmonary oedema complicating cytosine arabinoside therapy of leukaemia. Am J Med 70:256–261PubMedCrossRefGoogle Scholar
  28. 28.
    Ersek MT (1984) Clinical reviews in critical care. The adult leukemia patient in the intensive care unit. Heart Lung 13:183–193PubMedGoogle Scholar
  29. 29.
    Sherwood LM (1980) The multiple causes of hypercalcemia in malignant disease. N Engl J Med 303:1412–1413PubMedCrossRefGoogle Scholar
  30. 30.
    Armstong BA, Perez CA, Simpson JR, Hederman MA (1987) Role of irradiation in the management of superior vena cava syndrome. Int J Radiat Oncol Biol Phy 13:531–539CrossRefGoogle Scholar
  31. 31.
    Baniel J, Lombrozo R, Ziv Y, Wolloch Y (1988) Neutopenic enterocolitis. Acta Chir Scand 154:71–73PubMedGoogle Scholar
  32. 32.
    Girtanner RE, Dampo T, Alleyn JN, Averette HE (1981) Routine intensive care for pelvic exenterative operations. Surg Gynecol Obstet 153:657–659PubMedGoogle Scholar
  33. 33.
    Averette HE, Lichtinger M, Sevin BU, Girtanner RE (1984) Pelvic exenteration: A 15 year experience in a general metropolitan hospital. Am J Obstet Gynecol 150:179–184PubMedGoogle Scholar
  34. 34.
    Hinds CJ, Watson JD (1985) Intensive care. In: Shepherd JH, Monaghan JH (eds) Clinical gynaecological oncology. Blackwell Scientific Publications, Oxford, pp 351–368Google Scholar
  35. 35.
    Ewer MS, Ali MK, Atta MS, et al (1986) Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure. JAMA 256:3364–3366PubMedCrossRefGoogle Scholar
  36. 36.
    Peters SG, Meadows JA, Gracey DR (1988) Outcome of respiratory failure in haematologic malignancy. Chest 94:99–102PubMedCrossRefGoogle Scholar
  37. 37.
    Sculier JP, Ries F, Verboven N, Coune E, Klatersky J (1988) Role of intensive care unit in a medical oncology department. Eur J Cancer Clin Oncol 24:513–517PubMedCrossRefGoogle Scholar
  38. 38.
    Patrick DL, Danis M, Southerland LI, Hong G (1988) Quality of life following intensive care. J Gen Intern Med 3:218–223PubMedCrossRefGoogle Scholar
  39. 39.
    Poe RH, Wahl GW, Qazi R, et al (1986) Predictors of mortality in the immunocompromised patient with pulmonary infiltrates. Arch Intern Med 146:1304–1308PubMedCrossRefGoogle Scholar
  40. 40.
    Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: A severity of disease classification system. Crit Care Med 13:818–829PubMedCrossRefGoogle Scholar
  41. 41.
    Lister TA, Rohatiner AZS (1982) The treatment of acute myelogenous leukaemia in adults. Sem Hemat 19:172–191Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1990

Authors and Affiliations

  • C. J. Hinds
  • E. H. S. Yau

There are no affiliations available

Personalised recommendations